Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Event, Trade Show, Webcast

Medpace Holdings, Inc. to Present at Jefferies 2019 Healthcare Conference


Medpace Holdings, Inc. (Nasdaq: MEDP) ("Medpace") today announced that it will present at the following investor conference in June:

Jefferies 2019 Healthcare Conference
Location: New York, NY
Date: Tuesday, June 4, 2019
Presentation: 8:30 a.m. ET
Speakers: August Troendle, President & Chief Executive Officer, and Jesse Geiger, Chief Financial Officer & Chief Operating Officer, Laboratory Operations

A live webcast of each presentation will be accessible through the "Investors" section of the Company's website at www.medpace.com and will be available for replay following each event.

About Medpace

Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical, and medical device industries. Medpace's mission is to accelerate the global development of safe and effective medical therapeutics through its high-science and disciplined operating approach that leverages regulatory and therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system, and anti-viral and anti-infective. Headquartered in Cincinnati, Ohio, Medpace employs approximately 3,100 people across 36 countries.


These press releases may also interest you

at 14:30
OtoNexus Medical Technologies (OtoNexus) is proud to announce being voted winner of the WomenCorporateDirectors Foundation (WCD) inaugural "Launch Zone" competition for women-led companies, taking place in Santa Clara, CA. OtoNexus, led by CEO...

at 14:30
CNO Financial Group, a holding company for several national life and health insurance companies that serve middle-income Americans and retirees, was recognized by the Philadelphia Business Journal as one of the Healthiest Employers of Greater...

at 14:30
The "Market Spotlight: Thyroid Cancer" report has been added to ResearchAndMarkets.com's offering. This Market Spotlight report covers the thyroid cancer market, comprising key marketed and pipeline drugs, clinical trials, recent events and analyst...

at 14:30
Xoran Technologies' xCAT IQTM, a cone beam CT for brain and bone window imaging, was featured in a skull base pro-section course at the recently concluded Rhinoworld conference in Chicago, Illinois. The Dissection Dual Course at Rhinoworld focused...

at 14:27
Through a partnership with Wellspring Cancer Canada, the Canadian Cancer Society (CCS) is expanding its support system by introducing six new self-care support programs focused on wellness and resilience across Sydney, Halifax, Yarmouth and...

at 14:25
Biocom, the association representing the California life science industry, today announced a call for entries for the fourth annual Life Science Catalyst Awards. In addition, Biocom announced that it will now accept nominations from the Bay Area for...



News published on 21 may 2019 at 16:10 and distributed by: